Resources from the same session
What has changed and what's next in the 1L setting for r/m CC?
Presenter: Ana Oaknin
Session: Seagen - Driving towards the future of r/m cervical cancer treatment: Take a front seat for interactive expert perspectives on emerging and potential future therapy options
Resources:
Webcast
What's new and how can we improve 2L management of r/m CC?
Presenter: Isabelle Ray-Coquard
Session: Seagen - Driving towards the future of r/m cervical cancer treatment: Take a front seat for interactive expert perspectives on emerging and potential future therapy options
Resources:
Webcast
Key messages and close
Presenter: Ana Oaknin
Session: Seagen - Driving towards the future of r/m cervical cancer treatment: Take a front seat for interactive expert perspectives on emerging and potential future therapy options
Resources:
Webcast